A. Kumar, “EFAVIRENZ, A WELL KNOWN ANTIVIRAL DRUG, MIGHT BE A NEW OPTION IN THE TREATMENT OF CANCER”, Int J Pharm Pharm Sci, vol. 8, no. 7, pp. 6–7, Jul. 2016.